ANOTHER FIN-FSA RELEASE IN THE MATTER AGAINST DR DANKO KONCAR
Afarak Group SE (LSE: AFRK, NASDAQ: AFAGR) announced on 6 November 2025 that the Financial Supervisory Authority (FIN-FSA) has published information regarding Dr. Danko Koncar. Although the company explicitly stated this is not a direct company matter, Afarak was requested by FIN-FSA to inform its shareholders accordingly. This disclosure, despite being external to the company's immediate operations, could still be perceived by investors as having an indirect association or potential reputational implications, warranting careful consideration of its impact on the stock share price.
Select text to share a quote on X · sign in to keep highlights & notes in your AFRK notes
10:15 London, 12:15 Helsinki, 6 November 2025 - Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR)
ANOTHER FIN-FSA RELEASE IN THE MATTER AGAINST DR DANKO KONCAR
Stock Exchange Release
On 6 November 2025, the Financial Supervisory Authority (FIN-FSA) has published attached information. Although this is not a company matter, Afarak was requested by Fin-FSA to inform its shareholders accordingly.
Helsinki, November 6, 2025
AFARAK GROUP SE
Board of Directors
Distribution:
NASDAQ Helsinki
London Stock Exchange
Main media
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.